Sang‐We Kim
Sang‐We Kim publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.
- World rank
- #137,454 of 7,710,434 ranked researchers
- Rank in South Korea
- #715 of 162,609
- Works
- 396
- Citations
- 23k
- Citations per work
- 59.1
What does Sang‐We Kim research?
Sang‐We Kim's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences30175.9%
- Medicine30175.9%
- Everything else5714.5%
- Life Sciences389.6%
- 1Pulmonary and Respiratory Medicine39% of their works
- 2Oncology32% of their works
- 3Molecular Biology6% of their works
- 4Cancer Research4% of their works
- 5Radiology, Nuclear Medicine and Imaging3% of their works
- 6Surgery2% of their works
Research topics
Which keywords describe Sang‐We Kim's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Immunotherapy, Genomic Profiles and Small-Cell Lung Cancer.
- Radiosurgery
- Mutational Signatures
- HER2
- KRAS Mutations
- PD-1 and PD-L1
- Lung Cancer
- Small-Cell Lung Cancer
- Immunotherapy
- ALK Inhibitors
- Clinical Trials
- Targeted Therapy
- Chemotherapy
- EGFR Mutations
- Genomic Profiles
- CT Screening
- Immune Checkpoint Blockade
- Cetuximab
- Breast Cancer
- Cancer Genomics
- Brain Metastases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Targeted Therapy3443 topics
- Clinical Trials3202 topics
- Chemotherapy2644 topics
- ALK Inhibitors2101 topic
- EGFR Mutations2101 topic
- Immunotherapy1312 topics
- Genomic Profiles1101 topic
- Small-Cell Lung Cancer1101 topic
- CT Screening861 topic
- Lung Cancer861 topic
- Immune Checkpoint Blockade711 topic
- PD-1 and PD-L1711 topic
- Cetuximab421 topic
- KRAS Mutations421 topic
- Breast Cancer261 topic
- HER2261 topic
- Cancer Genomics241 topic
- Mutational Signatures241 topic
- Brain Metastases211 topic
- Radiosurgery211 topic
Where does Sang‐We Kim work?
Sang‐We Kim's main affiliation in the publication record is Asan Medical Center, South Korea.
How many publications and citations does Sang‐We Kim have?
OpenAlex counts 396 works and 23,394 citations for Sang‐We Kim, an h-index of 60, ranking #137,454 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Sang‐We Kim
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sang‐We Kim. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.